Can AI learn 'why it was wrong'? — World Model, RSI, AI for Science

This article is long. However, to make it worth revisiting, I have provided three guideposts. Guidepost 1: Confidence Labels ...

I asked an AI what it finds beautiful. Why not let an AI see my work, too?

When I asked an AI what it finds beautiful, it returned four lines of Python code.When you create a piece of work, you want ...
BIOENGINEER

TTFE: Mining top-k high-threat-and-frequency event sets in IIoT security

A benchmark study found that TTFE ranked IIoT event sets by combined threat and frequency while using less time and memory ...
Anthropic

LLMs are making formal software verification feasible at a much larger scale

Claude formally proved security properties in the compiled code of 123 open-source libraries. Along the way, it found bugs ...
BIOENGINEER

MRI heterogeneity maps predict pancreatic cancer nerve invasion

A multicenter retrospective study found that spatial heterogeneity measured across three MRI sequences predicted pancreatic ...
KDnuggets

Google Open-Sources Harness²: Self-Improving AI Agents Without Retraining

Google Research has open-sourced Harness² (Harness2), a framework that lets AI agents improve themselves without retraining ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...